ArticleDrug safety2018

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.

Giampiero Mazzaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.